Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for POSACONAZOLE
- Antimicrobial Revision in Persistent Febrile Neutropenia
- Amphotericin Versus Posaconazole for Pulmonary Mucormycosis
- Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study
- Pilot Study of Posaconazole in Crohn's Disease
- A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
- Azole-echinocandin Combination Therapy for Invasive Aspergillosis
- Neuro-pharmacological Study of Ketoconazole for High-grade Gliomas
- Neuro-pharmacological Study of Posaconazole for High-grade Gliomas: A Phase 0 Clinical Trial
- A Study of BGB-11417 in Participants With Myeloid Malignancies
- DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
- Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
- Prophylactic Anticoagulation for Catheter-related Thrombosis
- Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)
- Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia
- PTX3-targeted Antifungal Prophylaxis
- Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With the Tablets Formulation and Evaluation of the Po
- Azoles Targeting Recurrent High Grade Gliomas
- HDM201 Added to CT in R/R or Newly Diagnosed AML
- Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
- Posaconazole vs Itraconazole in Preventing IFD Post-HSCT
- Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants
- Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
- Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients
- Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
- Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients
- Dosing Obese With Noxafil® Under a Trial (DONUT)
- Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
- Drug/Drug Interactions With F901318
- Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia
- Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
- Invasives Aspergillosis in Acute Myeloid Leukemia
- King's Invasive Aspergillosis Study II
- Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections
- Anti-mold Azole in the Prophylaxis for Invasive Fusariosis
- Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
- Effect of Inflammation on Pharmacokinetics of Posaconazole
- Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
- Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)
- A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
- Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
- Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)
- Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
- Dose-finding of Rivaroxaban in Hemodialysis
- Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection.
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers
- A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors
- Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus
- A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
- Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)
- A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
- A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)
- Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
- Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease
- Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)
- A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
- Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine
- Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients
- Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
- Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
- Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)
- Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen
- Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
- Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
- Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)
- Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)
- Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)
- Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
- Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)
- Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)
- Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
- Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
- A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)
- A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)
- Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment
- POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
- Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095
- Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
- PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
- Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)
- Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease
- Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)
- Posaconazole to Treat Invasive Fungal Infections
- Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
- A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
Clinical trials list
click for details